Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
GlaxoSmithKline announced that the FDA has approved Flonase Allergy Relief (fluticasone propionate 50mcg spray) as a once-daily over-the-counter (OTC) treatment indicated for symptoms of seasonal and perennial allergic and nonallergic rhinitis in patients ≥4 years of age
For children with persistent asthma, use of inhaled corticosteroids (ICS) is associated with a significant reduction in linear growth velocity, with lower growth velocity for those receiving a higher dose of ICS.
Decreased variability of facial expression may help identify patients with serious cardiopulmonary disease in the emergency care setting.
Risk factors for sleep-related infant deaths vary with infant age and parents should be warned about the dangers of these specific risk factors appropriate to their infant's age.
This activity provides in-depth guidance for the pharmacologic and nonpharmacologic treatment of arthritis, and management ...
This activity will explain different ways to treat patients suffering from COPD using medications and ...